Healthcare provider profile · identity verified

Saigeetha Uthamarajan, MD

Geriatric Medicine · NOVI, MI · NPI 1386852952

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	595	154
Atorvastatin Calcium	Atorvastatin Calcium	563	144
Furosemide	Furosemide	349	68
Losartan Potassium	Losartan Potassium	312	82
Escitalopram Oxalate	Escitalopram Oxalate	301	69
Amlodipine Besylate	Amlodipine Besylate	288	76
Lisinopril	Lisinopril	287	74
Eliquis	Apixaban	258	57
Metoprolol Succinate	Metoprolol Succinate	243	60
Pantoprazole Sodium	Pantoprazole Sodium	209	37
Omeprazole	Omeprazole	206	62
Rosuvastatin Calcium	Rosuvastatin Calcium	192	55
Gabapentin	Gabapentin	175	44
Simvastatin	Simvastatin	175	48
Potassium Chloride	Potassium Chloride	173	36
Trazodone Hcl	Trazodone Hcl	162	30
Carvedilol	Carvedilol	143	29
Metoprolol Tartrate	Metoprolol Tartrate	136	34
Metformin Hcl	Metformin Hcl	133	39
Mirtazapine	Mirtazapine	132	22
Famotidine	Famotidine	107	22
Hydrochlorothiazide	Hydrochlorothiazide	104	29
Pravastatin Sodium	Pravastatin Sodium	92	18
Nifedipine Er	Nifedipine	88	15
Xarelto	Rivaroxaban	88	13
Tamsulosin Hcl	Tamsulosin Hcl	86	29
Allopurinol	Allopurinol	84	19
Alendronate Sodium	Alendronate Sodium	83	23
Montelukast Sodium	Montelukast Sodium	77	17
Donepezil Hcl	Donepezil Hcl	74	20
Sertraline Hcl	Sertraline Hcl	73	18
Duloxetine Hcl	Duloxetine Hcl	72	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	72	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	19
Finasteride	Finasteride	67	16
Hydralazine Hcl	Hydralazine Hcl	67	14
Albuterol Sulfate Hfa	Albuterol Sulfate	64	30
Atenolol	Atenolol	63	21
Clopidogrel	Clopidogrel Bisulfate	62	12
Glipizide Er	Glipizide	61	13
Tramadol Hcl	Tramadol Hcl	61	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	59	37
Cephalexin	Cephalexin	55	39
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	51	15
Alprazolam	Alprazolam	50	15
Memantine Hcl	Memantine Hcl	47	suppressed
Ipratropium Bromide	Ipratropium Bromide	46	17
Lovastatin	Lovastatin	43	suppressed
Solifenacin Succinate	Solifenacin Succinate	43	suppressed
Spironolactone	Spironolactone	43	16
Buspirone Hcl	Buspirone Hcl	41	12
Venlafaxine Hcl Er	Venlafaxine Hcl	41	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	30
Ramipril	Ramipril	36	suppressed
Azithromycin	Azithromycin	35	33
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	32	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Pregabalin	Pregabalin	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	28	28
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Telmisartan	Telmisartan	27	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	27	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	18
Warfarin Sodium	Warfarin Sodium	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Raloxifene Hcl	Raloxifene Hcl	23	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Mesalamine Er	Mesalamine	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Digoxin	Digoxin	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Torsemide	Torsemide	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Prednisone	Prednisone	16	13
Synthroid	Levothyroxine Sodium	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Nystatin	Nystatin	15	12
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	14	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Desonide	Desonide	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	12
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Estradiol	Estradiol	11	suppressed
Glipizide	Glipizide	11	suppressed
Letrozole	Letrozole	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Mresvia	Rsv Vaccine, Pref, Mrna/Pf	11	11
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error